MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
CorMedix ROCE Ratio 2011-2025 | CRMD
Annual ROCE Ratio CorMedix
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -69.8 | -55.62 | -46.88 | -60.29 | -88.83 | -242.9 | -457.7 | -138.99 | -48.92 | -242.41 | -379.94 | 657.33 | -579.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 657.33 | -579.3 | -134.94 |
Quarterly ROCE Ratio CorMedix
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.5 | 15.18 | -26.81 | -67.52 | -80.1 | -87.09 | -78.02 | -57.08 | -69.44 | -69.22 | -58.5 | -37.46 | -49.81 | -49.8 | -44.1 | -28.98 | -43.91 | -46.5 | -59.02 | -47.79 | -69.66 | -76.6 | -79.85 | -66.11 | -273.67 | -459.35 | -609.66 | -587.78 | -699.16 | -602.98 | -526.88 | -314.92 | -314.96 | -254.99 | -184.93 | -102.31 | -102.28 | -50.89 | -23.32 | -0.05 | -51.31 | -102.57 | -154.55 | -348.2 | -317.0 | -234.51 | -150.48 | 83.31 | 378.84 | 643.16 | 794.07 | 746.79 | 536.38 | 30.43 | -353.1 | -573.56 | -210.41 | -200.59 | -162.55 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 794.07 | -699.16 | -101.66 |
ROCE Ratio of other stocks in the Biotechnology industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M |  Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
-73.67 | $ 4.78 | -0.21 % | $ 793 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
-91.24 | $ 3.03 | -0.33 % | $ 234 M |  USA |
 |
Aptevo Therapeutics
APVO
|
-517.39 | $ 0.61 | -34.73 % | $ 168 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-104.38 | $ 3.12 | 0.81 % | $ 7.51 B |  Australia |
 |
Autolus Therapeutics plc
AUTL
|
-161.2 | $ 1.67 | -0.6 % | $ 426 M |  Britain |
 |
Alpine Immune Sciences
ALPN
|
-32.41 | - | - | $ 2.17 B | USA |
 |
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
-40.28 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-28.92 | - | 1.93 % | $ 17.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | USA |
 |
BioVie
BIVI
|
-95.03 | $ 1.21 | -4.72 % | $ 1.79 M | USA |
 |
AlloVir
ALVR
|
-57.76 | - | 4.14 % | $ 49.1 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-45.89 | $ 208.98 | -1.8 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | USA |
 |
Avenue Therapeutics
ATXI
|
-403.4 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
10.76 | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
19.77 | - | -4.8 % | $ 255 M | USA |
 |
Athersys
ATHX
|
-531.85 | - | 3.77 % | $ 22.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-1339.01 | - | -9.72 % | $ 5.89 M | USA |
 |
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M | Canada |
 |
Can-Fite BioPharma Ltd.
CANF
|
-115.03 | $ 0.21 | 22.23 % | $ 457 M |  Israel |
 |
Adaptimmune Therapeutics plc
ADAP
|
-353.66 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
-69.03 | - | -7.31 % | $ 87 M | USA |
 |
Catalyst Biosciences
CBIO
|
424.75 | $ 12.35 | -0.16 % | $ 813 M | USA |
 |
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | USA |
 |
BioNTech SE
BNTX
|
-4.81 | $ 94.52 | -0.54 % | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
28.05 | $ 27.12 | 1.16 % | $ 1.31 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-15.33 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
-1377.15 | - | -10.95 % | $ 876 K | USA |
 |
Certara
CERT
|
-0.16 | $ 8.89 | -0.22 % | $ 1.43 B | USA |
 |
Anika Therapeutics
ANIK
|
-41.29 | $ 9.55 | 0.74 % | $ 140 M | USA |
 |
bluebird bio
BLUE
|
-125.56 | - | - | $ 546 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-92.73 | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | USA |
 |
Axon Enterprise
AXON
|
2.51 | $ 583.84 | -1.24 % | $ 44.2 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-12.81 | $ 2.45 | -3.16 % | $ 15.4 M | USA |
 |
ChromaDex Corporation
CDXC
|
16.76 | - | -0.88 % | $ 598 M | USA |
 |
AstraZeneca PLC
AZN
|
11.12 | $ 92.9 | 0.49 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
-64.05 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
14.24 | $ 9.09 | 1.0 % | $ 1.47 B | Britain |
 |
Corcept Therapeutics Incorporated
CORT
|
20.15 | $ 82.65 | -1.12 % | $ 8.53 B | USA |